mRNA 平台市场：按适应症、用途性别、mRNA 类型和最终用户 - 2023-2030 年全球预测

全球 mRNA 平台市场预计到 2023 年将以 49.67%的年复合成长率大幅增长，达到 84.058 亿美元，预计到 2030 年将达到惊人的 1548.2021 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球mRNA平台市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球mRNA平台市场规模及预测为何？

2.在预测期内，COVID-19 对全球 mRNA 平台市场的阻碍因素和影响为何？

3.全球 mRNA 平台市场预测期间有哪些产品/细分市场/应用/领域值得投资？

4.mRNA平台在全球市场的竞争策略为何？

5.全球mRNA平台市场的技术趋势和法律规范是什么？

6.全球mRNA平台市场主要厂商的市占率为何？

7. 哪些型态和策略倡议被认为适合mRNA平台进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 与其他疫苗疗法相比，mRNA的显着优势
    • 使用 mRNA 平台开发癌症治疗方法
    • 疫苗开发和商业化时间需要缩短
  • 抑制因素
    • 最佳化製造和商业途径的复杂性
  • 机会
    • 市值增加和公共资金注入
    • 按需疫苗开发中 mRNA 技术的最佳化
    • 加强预防性和治疗性疫苗的开发
  • 任务
    • 高临床和法规风险
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章mRNA 平台市场（依指标）

• 自体免疫疾病
• 癌症
  • 个别治疗
  • 专注于单一癌症
• 感染疾病
• 罕见疾病
• 呼吸系统疾病

第7章mRNA 平台市场：按可用性

• 预防性疫苗
• 治疗药物
• 治疗性疫苗

第8章mRNA 平台市场（按 mRNA 类型）

• 核苷修饰的mRNA
• 自我扩增mRNA
• 未修饰的mRNA

第9章mRNA 平台市场：依最终用户划分

• 医院和诊所
• 製药公司
• 研究机构

第10章美洲mRNA平台市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第11章亚太mRNA平台市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第12章欧洲/中东/非洲mRNA平台市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第13章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

• 讨论指南
• 关于许可证和定价

The Global mRNA Platform Market is forecasted to grow significantly, with a projected USD 8,400.58 million in 2023 at a CAGR of 49.67% and expected to reach a staggering USD 154,820.21 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global mRNA Platform Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global mRNA Platform Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Autoimmune Diseases, Cancer, Infectious Diseases, Rare Diseases, and Respiratory Diseases. The Cancer is further studied across Personalized Treatment and Single Cancer Focussed. The Autoimmune Diseases is projected to witness significant market share during forecast period.

Based on Usability, market is studied across Prophylactic Vaccines, Therapeutic Drugs, and Therapeutic Vaccines. The Therapeutic Vaccines is projected to witness significant market share during forecast period.

Based on mRNA Type, market is studied across Nucleoside-Modified mRNA, Self-Amplifying mRNA, and Unmodified mRNA. The Self-Amplifying mRNA is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical Companies, and Research Organization. The Pharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global mRNA Platform Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global mRNA Platform Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global mRNA Platform Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global mRNA Platform Market?

4. What is the competitive strategic window for opportunities in the Global mRNA Platform Market?

5. What are the technology trends and regulatory frameworks in the Global mRNA Platform Market?

6. What is the market share of the leading vendors in the Global mRNA Platform Market?

7. What modes and strategic moves are considered suitable for entering the Global mRNA Platform Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. mRNA Platform Market, by Indication, 2022 vs 2030
• 4.3. mRNA Platform Market, by Usability, 2022 vs 2030
• 4.4. mRNA Platform Market, by mRNA Type, 2022 vs 2030
• 4.5. mRNA Platform Market, by End-User, 2022 vs 2030
• 4.6. mRNA Platform Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant mRNA advantages over other vaccine modalities
    • 5.1.1.2. Developing therapeutic cancer treatment, exploiting mRNA platform
    • 5.1.1.3. Need to reduce vaccine development and commercialization timeline
  • 5.1.2. Restraints
    • 5.1.2.1. Complexity in optimising manufacturing and commercial pathways
  • 5.1.3. Opportunities
    • 5.1.3.1. Increased market capitalization and public funding
    • 5.1.3.2. mRNA technology optimization on development of on-demand vaccines
    • 5.1.3.3. Increased development in prophylactic vaccines and therapeutic vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. High clinical and regulatory risk
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. mRNA Platform Market, by Indication

• 6.1. Introduction
• 6.2. Autoimmune Diseases
• 6.3. Cancer
  • 6.3.1. Personalized Treatment
  • 6.3.2. Single Cancer Focussed
• 6.4. Infectious Diseases
• 6.5. Rare Diseases
• 6.6. Respiratory Diseases

7. mRNA Platform Market, by Usability

• 7.1. Introduction
• 7.2. Prophylactic Vaccines
• 7.3. Therapeutic Drugs
• 7.4. Therapeutic Vaccines

8. mRNA Platform Market, by mRNA Type

• 8.1. Introduction
• 8.2. Nucleoside-Modified mRNA
• 8.3. Self-Amplifying mRNA
• 8.4. Unmodified mRNA

9. mRNA Platform Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Pharmaceutical Companies
• 9.4. Research Organization

10. Americas mRNA Platform Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific mRNA Platform Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa mRNA Platform Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. MRNA PLATFORM MARKET RESEARCH PROCESS
• FIGURE 2. MRNA PLATFORM MARKET SIZE, 2022 VS 2030
• FIGURE 3. MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 5. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2022 VS 2030 (%)
• FIGURE 6. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2022 VS 2030 (%)
• FIGURE 7. MRNA PLATFORM MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. MRNA PLATFORM MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. MRNA PLATFORM MARKET DYNAMICS
• FIGURE 10. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. MRNA PLATFORM MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. MRNA PLATFORM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 5. MRNA PLATFORM MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 7. MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. MRNA PLATFORM MARKET SIZE, BY PERSONALIZED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. MRNA PLATFORM MARKET SIZE, BY SINGLE CANCER FOCUSSED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. MRNA PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. MRNA PLATFORM MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 14. MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 18. MRNA PLATFORM MARKET SIZE, BY NUCLEOSIDE-MODIFIED MRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. MRNA PLATFORM MARKET SIZE, BY SELF-AMPLIFYING MRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. MRNA PLATFORM MARKET SIZE, BY UNMODIFIED MRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. MRNA PLATFORM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. MRNA PLATFORM MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. CHINA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 69. CHINA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. ITALY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 160. ITALY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. POLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 180. POLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. QATAR MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. QATAR MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 235. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 236. MRNA PLATFORM MARKET LICENSE & PRICING